Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nature Precision Oncology is a molecular diagnostics and precision medicine company based in India that specializes in advanced genomic testing for cancer care. The company leverages next-generation sequencing (NGS) and sophisticated bioinformatics to provide comprehensive genomic profiling, helping oncologists identify actionable mutations and select targeted therapies. Their service portfolio includes solid tumor profiling, liquid biopsy for non-invasive monitoring, and hereditary cancer screening to assess genetic risk. By integrating clinical data with molecular insights, the company aims to optimize treatment outcomes and facilitate personalized medicine in routine oncology practice. Nature Precision Oncology operates a state-of-the-art laboratory facility to ensure high-quality, reproducible results for patients and healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nature Precision Oncology.